Skip to main content
Log in

Serum protease inhibitors in acute viral hepatitis

  • Original Contributions
  • Published:
Ricerca in clinica e in laboratorio

Summary

Serum levels of α1-antitrypsin (α1-AT) and α2-macroglobulin (α2-M) and, as controls, α1-acid glycoprotein (α1-AG) and haptoglobin were evaluated by means of laser nephelometry in 17 patients with acute viral hepatitis (AVH) type A, 16 with AVH-B, 12 with AVH-NANB and 8 with fulminant hepatitis B. On admission, α1-AT levels were elevated in one third of AVH-A and AVH-B cases, but subsequently declined; α2-M levels were elevated in about 40% of AVH-B patients during the 2nd, 3rd and 4th week after admission. No significant correlation was found between elevated levels of protease inhibitors and aminotransferase values or drug addiction and δ coinfection. α1-acid glycoprotein and haptoglobin levels were always normal or low. Protease inhibitors did not show any elevation in fulminant hepatitis, while changes were found only in a few patients with AVH-NANB. Thus, no clearcut pattern of changes in protease inhibitors has been found in association with each type of hepatitis, although α1-AT and α2-M elevations are mainly found in AVH-B.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ades E. W., Hinson A., Chapuis-Cellier C.: Modulation of the immunoresponse by plasma protease inhibitors. I. Alpha2-macroglobulin and alpha1-antitrypsin inhibit natural killing and antibody-dependent cell-mediated cytotoxicity — Scand. J. Immunol.15, 109, 1982.

    Article  PubMed  CAS  Google Scholar 

  2. Arora P. K., Miller H. E., Aronson L. D.: α1-antitrypsin is an effector of immunological stasis — Nature (Lond.)174, 589, 1978.

    Article  Google Scholar 

  3. Berg P. A., Brattig N.: Die Bedeutung immunoregulativer Faktoren für die Beurteilung der Virushepatitis — Med. Klin.77, 419, 1982.

    Google Scholar 

  4. Breit S. N., Luckhurst E., Penny R.: The effect of α1-antitrypsin on the proliferative response of human peripheral blood lymphocytes — J. Immunol.130, 681, 1983.

    PubMed  CAS  Google Scholar 

  5. Carlson J., Eriksson S.: α1-antitrypsin and other acute phase reactants in liver disease — Acta med. scand.207, 79, 1980.

    PubMed  CAS  Google Scholar 

  6. Courtoy P. S., Lombart C., Feldmann G., Moguilevsky M., Rogier E.: Synchronous increase of four acute phase proteins synthesized by the same hepatocytes during the inflammatory reaction. A combined biochemical and morphologic kinetic study in the rat — Lab. Invest.44, 101, 1981.

    Google Scholar 

  7. Dinarello C. A.: Interleukin-1 and the pathogenesis of the acute phase response — New Engl. J. Med.22, 1413, 1984.

    Google Scholar 

  8. Garavagna P., Giannazza E., Arnoud P., Neels M., Ades E. W.: Modulation of the immune response by plasma protease inhibitors. II. Alpha2-macroglobulin subunits inhibit natural killer cell cytotoxicity and antibody-dependent cell-mediated cytotoxicity — Scand. J. Immunol.15, 115, 1982.

    Article  Google Scholar 

  9. Hubbard W. J., Hess A.D., Hsia S., Amos D. B.: The effects of electrophoretically ‘slow’ and ‘fast’ α2-macroglobulin on mixed lymphocyte cultures — J. Immunol.126, 292, 1981.

    PubMed  CAS  Google Scholar 

  10. Miescher P. A., Müller-Eberhard H. J. (Eds): Immunopathology of hepatitis B virus infection. Springer Seminars on Immunopathology. Springer-Verlag, New York, 1981.

    Google Scholar 

  11. Mondelli M., Mieli Vergani G., Alberti A., Vergani D., Portmann B., Eddleston A. L. W. F., Williams R.: Specificity of T-lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes — J. Immunol.129, 2773, 1982.

    PubMed  CAS  Google Scholar 

  12. Oppenheim J. J., Gery I.: Interleukin-1 is more than an interleukin — Immunol. Today3, 113, 1982.

    Article  CAS  Google Scholar 

  13. Pepys M. B., Dash A. C., Markham R. E.: Comparative clinical study of proteins SAP (amyloid P component) and C-reactive protein in serum — Clin. exp. Immunol.32, 119, 1978.

    PubMed  CAS  Google Scholar 

  14. Stefanini C. F., Bernardi M., Miglio F., Mariani E., Chiodo F., Facchini A., Labò G., Gasbarrini G.: Different mechanisms ofin vitro lymphocytotoxicity against isolated rabbit hepatocytes during the course of acute viral hepatitis — Digestion22, 229, 1981.

    Article  PubMed  CAS  Google Scholar 

  15. Van Gool J.: Profiles of acute phase reactants and clinical significance of α2-macroglobulin in acute hepatitis B — Inflammation7, 277, 1983.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was partially supported by grants fromConsiglio Nazionale delle Ricerche (CNR) andMinistero della Pubblica Istruzione, Roma, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meliconi, R., Parracino, O., Facchini, A. et al. Serum protease inhibitors in acute viral hepatitis. La Ricerca Clin. Lab. 17, 53–59 (1987). https://doi.org/10.1007/BF02909389

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02909389

Key-words

Navigation